Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Hörner

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Organic & Biomolecular Chemistry|January 11, 2013
Bioconjugation on cube-octameric silsesquioxanesSebastian Fabritz, Sebastian Hörner, Olga Avrutina, et al.
Biotechnology and Bioengineering|May 14, 2021
Mass spectrometry for quality control of bispecific antibodies after SDS-PAGE in-gel digestionSebastian Hörner, Michael Ghosh, Joseph Kauer, et al.
ACS Chemical Biology|July 2, 2015
Self-Assembled Hybrid Aptamer-Fc Conjugates for Targeted Delivery: A Modular Chemoenzymatic ApproachStephan Dickgiesser, Nicolas Rasche, Daichi Nasu, et al.
Angewandte Chemie (International Ed. in English)|July 30, 2014
A chemoenzymatic approach to protein immobilization onto crystalline cellulose nanoscaffoldsChristina Uth, Stefan Zielonka, Sebastian Hörner, et al.
Organic & Biomolecular Chemistry|December 20, 2012
Cube-octameric silsesquioxane-mediated cargo peptide delivery into living cancer cellsSebastian Hörner, Sebastian Fabritz, Henry D Herce, et al.
Angewandte Chemie (International Ed. in English)|October 25, 2016
Nanoscale Biodegradable Organic-Inorganic Hybrids for Efficient Cell Penetration and Drug DeliverySebastian Hörner, Sascha Knauer, Christina Uth, et al.
Cancers|September 28, 2021
CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific AntibodiesJoseph Kauer, Fabian Vogt, Ilona Hagelstein, et al.
Organic & Biomolecular Chemistry|June 27, 2012
From pico to nano: biofunctionalization of cube-octameric silsesquioxanes by peptides and miniproteinsSebastian Fabritz, Sebastian Hörner, Doreen Könning, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2022
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitroJoseph Kauer, Melanie Märklin, Martin Pflügler, et al.
Frontiers in Immunology|March 16, 2026
Generation and preclinical characterization of a novel bispecific CD19-TCRgammadelta antibody for the treatment of B cell acute lymphoblastic leukemiaJoseph Kauer, Fabian Vogt, Sebastian Hörner, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Organic & Biomolecular Chemistry|January 11, 2013
Bioconjugation on cube-octameric silsesquioxanesSebastian Fabritz, Sebastian Hörner, Olga Avrutina, et al.
Biotechnology and Bioengineering|May 14, 2021
Mass spectrometry for quality control of bispecific antibodies after SDS-PAGE in-gel digestionSebastian Hörner, Michael Ghosh, Joseph Kauer, et al.
ACS Chemical Biology|July 2, 2015
Self-Assembled Hybrid Aptamer-Fc Conjugates for Targeted Delivery: A Modular Chemoenzymatic ApproachStephan Dickgiesser, Nicolas Rasche, Daichi Nasu, et al.
Angewandte Chemie (International Ed. in English)|July 30, 2014
A chemoenzymatic approach to protein immobilization onto crystalline cellulose nanoscaffoldsChristina Uth, Stefan Zielonka, Sebastian Hörner, et al.
Organic & Biomolecular Chemistry|December 20, 2012
Cube-octameric silsesquioxane-mediated cargo peptide delivery into living cancer cellsSebastian Hörner, Sebastian Fabritz, Henry D Herce, et al.
Angewandte Chemie (International Ed. in English)|October 25, 2016
Nanoscale Biodegradable Organic-Inorganic Hybrids for Efficient Cell Penetration and Drug DeliverySebastian Hörner, Sascha Knauer, Christina Uth, et al.
Cancers|September 28, 2021
CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific AntibodiesJoseph Kauer, Fabian Vogt, Ilona Hagelstein, et al.
Organic & Biomolecular Chemistry|June 27, 2012
From pico to nano: biofunctionalization of cube-octameric silsesquioxanes by peptides and miniproteinsSebastian Fabritz, Sebastian Hörner, Doreen Könning, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2022
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitroJoseph Kauer, Melanie Märklin, Martin Pflügler, et al.
Frontiers in Immunology|March 16, 2026
Generation and preclinical characterization of a novel bispecific CD19-TCRgammadelta antibody for the treatment of B cell acute lymphoblastic leukemiaJoseph Kauer, Fabian Vogt, Sebastian Hörner, et al.
Pageof 2